B7/CD28 costimulation of T cells induces a distinct proteome pattern

Mol Cell Proteomics. 2005 Dec;4(12):1876-87. doi: 10.1074/mcp.M500194-MCP200. Epub 2005 Aug 19.

Abstract

Effective immune strategies for the eradication of human tumors require a detailed understanding of the interaction of tumor cells with the immune system, which might lead to an optimization of T cell responses. To understand the impact of B7-mediated costimulation on T cell activation comprehensive proteome analysis of B7-primed T cell populations were performed. Using this approach we identified different classes of proteins in T cells whose expression is either elevated or reduced upon B7-1- or B7-2-mediated CD28 costimulation. The altered proteins include regulators of the cell cycle and cell proliferation, signal transducers, components of the antigen processing machinery, transporters, cytoskeletal proteins, and metabolic enzymes. A number of differentially expressed proteins are further modified by phosphorylation. Our results provide novel insights into the complexity of the CD28 costimulatory pathway of T cells and will help to identify potential targets of therapeutic interventions for modulating anti-tumor T cell activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / immunology*
  • Base Sequence
  • Blood Proteins / isolation & purification
  • CD28 Antigens / immunology*
  • Carcinoma, Renal Cell
  • Cell Line, Tumor
  • DNA Primers
  • Electrophoresis, Gel, Two-Dimensional
  • Gene Expression Regulation
  • HLA-A2 Antigen / blood
  • Humans
  • Kidney Neoplasms
  • Leukocytes, Mononuclear / immunology
  • Lymphocyte Activation
  • Mass Spectrometry
  • Phosphoproteins / genetics
  • Phosphoproteins / isolation & purification
  • Proteome / genetics
  • Proteome / immunology*
  • T-Lymphocytes / immunology*

Substances

  • Antigens, CD
  • Blood Proteins
  • CD28 Antigens
  • DNA Primers
  • HLA-A2 Antigen
  • Phosphoproteins
  • Proteome